A Simple Guide to Software Development
Software development is becoming more and more important in the digital age. It’s no wonder,…
Month: April 2023
Celularity’s Dr. Robert Hariri To Co-Chair The 2023 International Precision Medicine Center (IPMC) Conference “Beyond Longevity: Live 120 Like 50™”
Hariri, Celularity’s CEO, Chairman and Founder, will open the meeting with the keynote address highlighting…
Celularity’s Dr. Robert Hariri To Co-Chair The 2023 International Precision Medicine Center (IPMC) Conference “Beyond Longevity: Live 120 Like 50™”
Hariri, Celularity’s CEO, Chairman and Founder, will open the meeting with the keynote address highlighting…
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
– 2022 marks Ceapro’s best performance in Company history with record sales of $18,800,000 compared…
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
– 2022 marks Ceapro’s best performance in Company history with record sales of $18,800,000 compared…
Tenax Therapeutics Provides 2023 Business Update
Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary…
AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)
Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical…
Tenax Therapeutics Provides 2023 Business Update
Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary…
Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine
CINCINNATI, April 12, 2023 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)
Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical…
Century Therapeutics Announces Leadership Changes
– Lalo Flores, Ph.D., steps down as Chief Executive Officer and member of Board of Directors;…
Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine
CINCINNATI, April 12, 2023 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
Century Therapeutics Announces Leadership Changes
– Lalo Flores, Ph.D., steps down as Chief Executive Officer and member of Board of Directors;…
First Patient Enrolled in JDRF-Funded Phase II Trial of CPP-1X-T for Recent Onset Type I Diabetes, Led by Indiana University School of Medicine
MINNEAPOLIS, April 12, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company…
First Patient Enrolled in JDRF-Funded Phase II Trial of CPP-1X-T for Recent Onset Type I Diabetes, Led by Indiana University School of Medicine
MINNEAPOLIS, April 12, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company…
Pliant Therapeutics to Participate in the 22nd Annual Needham Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Pliant Therapeutics to Participate in the 22nd Annual Needham Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
BRISBANE, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
BRISBANE, Calif., April 12, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage…
Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program
New program will increase access to affordable genetic testing while also helping to identify and…